Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eliem Therapeutics
Biotech
Double autoimmune acquisitions as Century, Eliem pick up peers
It’s been a busy morning for business development in the autoimmune space, with Century snapping up Clade and Eliem buying Tenet Medicines.
James Waldron
Apr 11, 2024 9:06am
Eliem cuts in on Tango, proposing acquisition after review
Mar 19, 2024 10:57am
Eliem shuts down final drug program 5 months after major layoffs
Jul 20, 2023 9:05am
Eliem axes depression drug, lays off 55% of team to stretch cash
Feb 10, 2023 6:00am
Chasing Biogen and Sage, Eliem puts depression drug into phase 2
Oct 5, 2022 10:20am
3-peat Friday: Castle Creek, Eliem and Adagio file for IPOs
Jul 19, 2021 8:57am